Home › Funds › UBS Group AG › DMAC
UBS Group AG position in DMAC
DIAMEDICA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)22.85K sh
Reported value held$160.86K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 4.62K | $17.00K | New |
| Q1 2022 | 950 | $2.00K | Reduce |
| Q2 2022 | 3.03K | $6.00K | Add |
| Q3 2022 | 7.19K | $9.00K | Add |
| Q4 2022 | 3.76K | $5.94K | Reduce |
| Q1 2023 | 2.04K | $3.12K | Reduce |
| Q3 2023 | 84 | $217 | New |
| Q1 2024 | 1.93K | $5.33K | New |
| Q3 2024 | 12.74K | $53.38K | New |
| Q4 2024 | 1.77K | $9.61K | Reduce |
| Q1 2025 | 4.38K | $16.61K | Add |
| Q2 2025 | 8.27K | $32.24K | Add |
| Q3 2025 | 13.34K | $91.65K | Add |
| Q4 2025 | 3.61K | $28.70K | Reduce |
| Q1 2026 | 8.66K | $58.63K | Add |
| Q2 2026 | 22.85K | $160.86K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DMAC
- BlackRock Inc 2.25M sh · $15.86M · Q2 2026
- Geode Capital Management 894.12K sh · $6.30M · Q2 2026
- Millennium Management 845.31K sh · $5.95M · Q2 2026
- Vanguard Group 723.12K sh · $5.76M · Q4 2025
- Northern Trust Corp 327.52K sh · $2.31M · Q2 2026
- Goldman Sachs Group 168.07K sh · $1.18M · Q2 2026
- Citadel Advisors 145.87K sh · $1.03M · Q2 2026
- BNY Mellon 117.82K sh · $829.45K · Q2 2026
- Charles Schwab Investment Management 96.69K sh · $680.71K · Q2 2026
- Bank of America Corp 57.71K sh · $406.29K · Q2 2026
- Morgan Stanley 46.87K sh · $329.99K · Q2 2026
- Wells Fargo & Co 36.93K sh · $259.97K · Q2 2026